Ameriprise’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02B | Sell |
7,287,230
-513,188
| -7% | -$71.9M | 0.24% | 96 |
|
|
2025
Q4 | $957M | Buy |
7,800,418
+652,013
| +9% | +$79.2M | 0.22% | 97 |
|
|
2025
Q3 | $794M | Buy |
7,148,405
+400,002
| +6% | +$45.5M | 0.18% | 112 |
|
|
2025
Q2 | $748M | Buy |
6,748,403
+5,392,191
| +398% | +$574M | 0.18% | 114 |
|
|
2025
Q1 | $152M | Buy |
1,356,212
+25,659
| +2% | +$2.65M | 0.04% | 394 |
|
|
2024
Q4 | $123M | Sell |
1,330,553
-561,251
| -30% | -$50.5M | 0.03% | 474 |
|
|
2024
Q3 | $159M | Sell |
1,891,804
-101,451
| -5% | -$7.74M | 0.04% | 393 |
|
|
2024
Q2 | $137M | Buy |
1,993,255
+367,878
| +23% | +$24.6M | 0.04% | 411 |
|
|
2024
Q1 | $119M | Buy |
1,625,377
+36,246
| +2% | +$2.79M | 0.03% | 475 |
|
|
2023
Q4 | $129M | Sell |
1,589,131
-114,652
| -7% | -$8.92M | 0.04% | 437 |
|
|
2023
Q3 | $128M | Buy |
1,703,783
+115,189
| +7% | +$8.86M | 0.04% | 407 |
|
|
2023
Q2 | $122M | Sell |
1,588,594
-90,181
| -5% | -$7.19M | 0.04% | 441 |
|
|
2023
Q1 | $139M | Buy |
1,678,775
+204,240
| +14% | +$16.9M | 0.05% | 394 |
|
|
2022
Q4 | $127M | Sell |
1,474,535
-137,378
| -9% | -$10.9M | 0.04% | 410 |
|
|
2022
Q3 | $100M | Sell |
1,611,913
-52,441
| -3% | -$3.31M | 0.04% | 457 |
|
|
2022
Q2 | $102M | Sell |
1,664,354
-172,999
| -9% | -$10.7M | 0.04% | 473 |
|
|
2022
Q1 | $105M | Buy |
1,837,353
+398,731
| +28% | +$25.5M | 0.03% | 518 |
|
|
2021
Q4 | $102M | Buy |
1,438,622
+238,965
| +20% | +$16.5M | 0.03% | 566 |
|
|
2021
Q3 | $83.8M | Sell |
1,199,657
-2,587,398
| -68% | -$182M | 0.03% | 569 |
|
|
2021
Q2 | $261M | Sell |
3,787,055
-157,445
| -4% | -$10.5M | 0.08% | 258 |
|
|
2021
Q1 | $255M | Sell |
3,944,500
-632,551
| -14% | -$40.8M | 0.08% | 240 |
|
|
2020
Q4 | $268M | Sell |
4,577,051
-59,296
| -1% | -$3.58M | 0.1% | 229 |
|
|
2020
Q3 | $291M | Buy |
4,636,347
+141,898
| +3% | +$9.84M | 0.12% | 189 |
|
|
2020
Q2 | $346M | Sell |
4,494,449
-1,727,247
| -28% | -$132M | 0.15% | 146 |
|
|
2020
Q1 | $468M | Sell |
6,221,696
-942,965
| -13% | -$65.2M | 0.25% | 84 |
|
|
2019
Q4 | $466M | Sell |
7,164,661
-193,192
| -3% | -$12.6M | 0.19% | 110 |
|
|
2019
Q3 | $466M | Sell |
7,357,853
-728,023
| -9% | -$47.6M | 0.21% | 101 |
|
|
2019
Q2 | $547M | Buy |
8,085,876
+503,477
| +7% | +$33.1M | 0.24% | 83 |
|
|
2019
Q1 | $493M | Buy |
7,582,399
+3,714
| +0% | +$247K | 0.23% | 84 |
|
|
2018
Q4 | $474M | Buy |
7,578,685
+1,381,794
| +22% | +$96.6M | 0.24% | 86 |
|
|
2018
Q3 | $487M | Sell |
6,196,891
-87,350
| -1% | -$6.6M | 0.17% | 126 |
|
|
2018
Q2 | $445M | Buy |
6,284,241
+996,408
| +19% | +$70.4M | 0.2% | 107 |
|
|
2018
Q1 | $399M | Buy |
5,287,833
+151,184
| +3% | +$12M | 0.18% | 124 |
|
|
2017
Q4 | $368M | Sell |
5,136,649
-369,059
| -7% | -$28M | 0.17% | 135 |
|
|
2017
Q3 | $446M | Buy |
5,505,708
+2,524,657
| +85% | +$193M | 0.21% | 105 |
|
|
2017
Q2 | $211M | Sell |
2,981,051
-675,200
| -18% | -$44.9M | 0.11% | 203 |
|
|
2017
Q1 | $248M | Buy |
3,656,251
+831,432
| +29% | +$58.5M | 0.13% | 171 |
|
|
2016
Q4 | $202M | Buy |
2,824,819
+360,343
| +15% | +$26.8M | 0.11% | 193 |
|
|
2016
Q3 | $195M | Sell |
2,464,476
-1,447,777
| -37% | -$118M | 0.11% | 192 |
|
|
2016
Q2 | $326M | Sell |
3,912,253
-441,422
| -10% | -$39.2M | 0.19% | 115 |
|
|
2016
Q1 | $400M | Sell |
4,353,675
-1,102,529
| -20% | -$99.4M | 0.24% | 90 |
|
|
2015
Q4 | $550M | Sell |
5,456,204
-1,562,303
| -22% | -$163M | 0.32% | 66 |
|
|
2015
Q3 | $688M | Sell |
7,018,507
-624,593
| -8% | -$69.4M | 0.43% | 47 |
|
|
2015
Q2 | $895M | Sell |
7,643,100
-1,001,910
| -12% | -$109M | 0.51% | 37 |
|
|
2015
Q1 | $848M | Sell |
8,645,010
-318,442
| -4% | -$32.3M | 0.49% | 40 |
|
|
2014
Q4 | $845M | Sell |
8,963,452
-5,336,100
| -37% | -$552M | 0.49% | 36 |
|
|
2014
Q3 | $1.52B | Sell |
14,299,552
-3,715,590
| -21% | -$364M | 0.92% | 10 |
|
|
2014
Q2 | $1.49B | Sell |
18,015,142
-691,833
| -4% | -$53.9M | 0.88% | 9 |
|
|
2014
Q1 | $1.33B | Sell |
18,706,975
-1,388,441
| -7% | -$109M | 0.8% | 10 |
|
|
2013
Q4 | $1.51B | Sell |
20,095,416
-1,486,394
| -7% | -$103M | 0.91% | 7 |
|
|
2013
Q3 | $1.36B | Sell |
21,581,810
-284,797
| -1% | -$17M | 0.89% | 8 |
|
|
2013
Q2 | $1.12B | Buy |
+21,866,607
| New | +$1.14B | 0.78% | 12 |
|
Other funds holding GILD
VCM
VPM
Ameriprise's GILD Position: Q1 2026 in Review
Ameriprise reduced its Gilead Sciences (GILD) stake by 6.6% in Q1 2026, selling an estimated $71.9M and leaving 7,287,230 shares worth $1.02B. The position accounts for 0.24% of the portfolio, ranked #96.
Ameriprise first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.52B in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Ameriprise held 7,287,230 shares of Gilead Sciences worth $1.02B as of Q1 2026.
- Ameriprise sold 513,188 Gilead Sciences shares in Q1 2026, an estimated $71.9M.
- Gilead Sciences made up 0.24% of Ameriprise's portfolio in Q1 2026, its #96 holding.
- Ameriprise first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Gilead Sciences position peaked at $1.52B in Q3 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.